Other Ingredients:Micosolle® a silica-based excipient containing a non-ionic surfactant, microcrystalline cellulous, vegetable oil, vegetable wax, silica, vegetable lubricant.
Precautions: Pregnenolone is a pro-hormone meaning it may change levels of other hormones including testosterone, DHEA, estrogen or progesterone. Do NOT take pregnenolone if you have or have had a hormonally-sensitive cancer such as breast or prostate cancer or hormonally-sensitive conditions such as PMS, PCOS or fibrocystic breast disease. Do not take pregnenolone if you have a history of seizures.
Side effects: Some people have reported insomnia and overstimulation from taking pregnenolone although others report that it makes them sleepy and take it at night. Irritability and anxiety have also been reported.
Suggested Dosage: Take 1 tablet per day during the dosing period. As a steroidal hormone, this product is not intended for long term continuous use. Consult a medical practitioner for individual dosing instructions.
Ray & Terry’s Pregnenolone contains 60 scored tablets per bottle. Each tablet contains 25 mg of pregnenolone.
The metabolism of pregnenolone affects energy levels in the body. Supplementation with pregnenolone may help fight fatigue in healthy individuals by modulating hormones such as DHEA and progesterone.4,5
Pregnenolone levels decrease with age, as do most other vital hormones and nutrients in the body.
Natural hormones dosed in capsules are almost entirely expelled by the liver during the first pass. This is called the ‘first pass effect.’ Our tablets are designed for lymphatic absorption to avoid this effect and offer superior absorption compared to most competing products. The manufacturer developed the BLA System™ (Bio-available lymphatic absorption), which uses micronization of the active ingredients in a lipid matrix to avoid the first pass effect and offer absorption and release over 8+ hours. Bio-availability through this system has been affirmed through extensive blood level testing.
Our pregnenolone formulation was initially developed for use in a pharmaceutical environment. It is produced in the same way as the original, but is non-prescription strength.
- Reddy DS. Prog Brain Res. 2010;186:113-37. Review.
- Petit GH, et al. Eur Neuropsychopharmacol. 2011 Feb;21(2):211-5. Epub 2010 Oct 30.
- Zheng P. Prog Neurobiol. 2009 Oct;89(2):134-52. Epub 2009 Jul 10. Review.
- Murphy BE, et al. Psychoneuroendocrinology. 2004 Feb;29(2):245-68.
- Ahboucha S, et al. Neurochem Int. 2008 Mar-Apr;52(4-5):569-74. Epub 2007 Jun 19.